A Phase II Trial of R115777 [tipifarnib] in Myelofibrosis With Myeloid Metaplasia (MMM).

Trial Profile

A Phase II Trial of R115777 [tipifarnib] in Myelofibrosis With Myeloid Metaplasia (MMM).

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2013

At a glance

  • Drugs Tipifarnib (Primary)
  • Indications Essential thrombocythaemia; Myelofibrosis; Polycythaemia vera
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Jan 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top